Our aim to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Toxicology.
To provide a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent solutions adopted in the fields of Toxicology.
April 28, 2021
Early Bird Registration
March 30, 2021
August 26-28, 2021
PAGES extend our immense pleasure and honor to invite all medical professionals, clinicians, and researchers to attend “Global Conference on Toxicology”, scheduled on August 26-28, 2021 in Paris, France. This inspiring event will include keynote presentations, oral talks and workshops that focus on emerging research and suggest practical solutions to current challenges in these fields.
Global Conference on Toxicology (GCT-2021), which will be held during August 26-28, 2021 at Paris, France is now an established event, attracting global participant’s intent on sharing, exchanging and exploring new avenues of Toxicology and related research and latest developments. The event will have 5-6 world level (Highly cited class) plenary speakers, established Keynote speakers, active Invited speakers and fresh contributed speakers. In addition, variety of poster presentations along with workshops and special sessions would be interested in audience.
It offers a wonderful opportunity for all the stake holders to collaborate with each other and make lasting connections that will enhance network and research goals. We hope this conference will help in discovering new avenues in research.
We look forward to welcome you at GCT -2021 in Paris, France.
Why to Attend???
Who Should Attend and Who You’ll Meet
Directors/Senior Directors/Executive Directors, CEO’s, Presidents/Vice Presidents, Heads/Leaders, Partners, Research Associates, Toxicologists and Research Scientist of Toxicology.
Deans, Professors/ Associate Professors/ Assistant Professors, Research Scholars, Scientists and Students related to Toxicology research.
Guidelines for the Abstract Submission:
University of KentuckyUSA
Dr. Xiaoqi Liu is the current Chair and Professor of Department of Toxicology and Cancer Biology, Lucille P. Markey Endowed Chair in Oncology Research, Markey Cancer Center at the University of Kentucky. Dr. Liu has a broad background in cancer biology, with specific training and expertise in signaling transduction, cell cycle regulation, DNA damage repair, and therapy resistance in the context of prostate cancer (PCa). Dr. Liu received his BS in chemistry at Peking University in 1991, and MS in Institute of Biophysics at Chinese Academy of Science in 1994. Dr. Liu received his Ph.D. at Washington State University in 1999 by working on DNA repair of UV-induced DNA damage. Dr. Liu did his post-doctoral training at Harvard University by working on signal transduction in mitosis, particularly polo-like kinase 1 (Plk1). Dr. Liu started his independent laboratory at Purdue University in 2006 by focusing on understanding the regulation of Plk1 in cancer cells. Dr. Liu has published 100 peer-reviewed research articles so far. Dr. Liu’s research program has been well funded by various agencies including NSF, ACS, and NIH. At this moment, Dr. Liu has four active R01s, all of which are prostate cancer-focused. In short, Dr. Liu has established his reputation as one of major contributors of the Plk1 field over the last 20 years. In 2018, Dr. Liu was recruited to the University of Kentucky as Chair of the Department of Toxicology and Cancer Biology.
Itamar Raz MD is board-certified, full professor in internal medicine, and was the Head of the Diabetes Unit at Hadassah Hebrew University Hospital from 2000-2015. He is currently Medical Director at the Diabetes Medical Center in Tel Aviv. In addition to his practice of medicine, Prof. Raz has been involved in many various academic activities. • He has organized and led one of the largest and prominent conferences in the prevention and treatment of diabetes, obesity and hypertension - Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) take place in Europe, South America, and Asia. The latest meeting was held virtually and had over 20,000 participants. The proceedings from several of these meetings have been published in Diabetes Care supplements, a publication of the American Diabetes Association. • Prof. Raz is a member of the Diabetes Experts Forum, a group of worldwide top experts who publish manuscripts on important topics in the treatment of diabetes and its complications in the journal, Diabetes Care. • Itamar Raz and his colleagues have developed guidelines for the treatment of diabetes that are used by physicians throughout the country, under the auspices of the Israel Diabetes Association. • In addition, Prof. Raz has been involved in developing policies in Israel and abroad for the prevention of obesity, diabetes, and hypertension in young children, adolescents, and adults. • He has been a co-principal investigator in several multicenter and large cardiovascular outcome trials (with around 17,000 patients) testing new drugs for the prevention and treatment of complications of diabetes. • He is a co-editor of several leading international diabetes journals (Diabetes & Metabolism Research and Reviews, International Diabetes Federation official journal, Drugs, Diabetes Obesity and Metabolism) and has published nearly 400 papers in the field of diabetes and its’ complications in many important medical journals.
Technion Faculty of MedicineIsrael
Zeev Blumenfeld is MD for Hebrew University and Hadassah Medical School, Jerusalem, and he is the Director for Reproductive Endocrinology for the department Obstetrics & Gynecology. He worked as Director in the year 2010 for Reproductive Endocrinology; he is a Senior Physician for Reproductive Endocrinology and Infertility, OB/GYN. He has extensive and vast teaching experience in the field of "Reproductive Endocrinology". He taught Director of Endocrinology Course for medical & graduate students, Director of “Physiology of Reproduction” course. He worked as a Reviewer for many scientific Journals. He also has a membership for International and National professional societies. He Elected as a member of the "Society for Gynecologic Investigation". Worked as Editor in Chief- ‘Clinical Medicine Insight: Reproductive Health’, "Journal of Reproductive Biology and Health". Zeev Blumenfeld advanced studies: 1983-1985 Fellowship in Reproductive Endocrinology in the Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, 1993- Exon-Intron Workshop on Molecular Biology - Recombinant DNA Methodology, 1993. 2014- Completed the program of GCP & clinical trials management for PI's. He had 297 Publications in Scopus. His Impact measure calculated using publication.
University of NantesFrance
Dr. Michel Bourin is currently serving as a psychiatrist in handicapped adults in Montredon(near Narbonne). He served as Professor of Pharmacology at the University of Nantes, Nantes, France, where he has been Head of Research in the Neurobiology of anxiety and depression from 1985 to 2009. He also served as a WHO expert for drug dependence (2000-2016). He was also an adjunct professor of the Department of Psychiatry at Edmonton University in Alberta, Canada, and is still a visiting professor at the University of Craiova in Romania, Dr. Bourin has published more than 350 original articles in the field of psychopharmacology and psychiatry, and more than 200 educational/review articles or book chapters, in both English and French. He published and wrote 12 books in French.
University of BelgradeSerbia
Dr. Mirjana Čolović is a graduate engineer of technology for biochemical engineering and biotechnology and a Ph.D. in chemistry and chemical technology (the University of Belgrade, Faculty of Technology and Metallurgy, Serbia). Since 2005 she has been employed at University of Belgrade, “Vinča” Institute of Nuclear Sciences, Department of Physical Chemistry, Serbia (current position-senior research associate). Dr. Mirjana Čolović's research activities have been taking place in the field of enzymology, medical and bioinorganic chemistry, and toxicology. Her PhD thesis was directed to the development of batch and flow cholinesterase based systems for insecticide detection and neurotoxicity evaluation and to in vitro evaluation of non-specific toxic effects of insecticides by monitoring prooxidative and cyto/genotoxic properties. In 2008, she started investigation on pharmacological properties of (newly) synthesized metal-based compounds for the purpose of new drug development, which includes interactions between the biologically active compounds and enzyme targets (cholinesterases, ATPases) in cancer and neurological diseases, in vitro prooxidative, cyto- and genotoxic effects on various isolated human and animal model cells, and in vivo antidiabetic properties and toxicity evaluation by monitoring various biomarkers of nephron- and hepatotoxicity. Mirjana Čolović's scientific outcome involves more than 100 scientific contributions - ˃40 papers in impacted international journals, 4 chapters in books, https://orcid.org/0000-0001-5037-9985, Scopus ID: 23566649100. She has been engaged as a participant/leader in 2 national and 5 international scientific projects, and as a referee in ˃20 international journals and 9 foreign projects. Her citation score is more than 1300 (Scopus). Furthermore, she has been an associate editorial board member (Current Medicinal Chemistry, Mini-Reviews in Medicinal Chemistry), an editorial board member (International Journal of Bioorganic Chemistry), a scientific committee member (3 conferences/workshops), an organizing committee member (1 workshop), and a management committee member/participant (4 COST actions).
University of BelgradeSerbia
Prof. Dr. Danijela Krstić obtained her BSc. MSc. and Ph.D. in biochemistry from the Faculty of Chemistry, University of Belgrade, Serbia. Works as a Full Professor of Medical Chemistry at Faculty of Medicine, University of Belgrade. The main fields of her research activities are 1) Enzymology: enzyme inhibition and kinetics; 2) Toxicology: in vitro and in vivo toxicity evaluation of newly synthesized and standard pharmacologically and physiologically active compounds, toxicity biomarkers: cytotoxicity and genotoxicity assays, oxidative stress parameters, biochemical markers of neuro-, nephro- and hepatotoxicity; and 3) Medicinal chemistry: interactions between the target enzymes and biologically active molecules (drugs, novel potential drugs, metal-based compounds, pesticides). She published more than 50 scientific papers in impacted international journals and her citation score is higher than 1500 (Scopus), https://orcid.org/0000-0002-9192-8087; Scopus Author ID: 57199836500. Dr. Danijela Krstić has been engaged as a leader/participant in 4 national and 5 international scientific projects.
Faculty of Pharmacy
Dr. Tarek Mohamed Kamal Mohamed Metawie, Professor of Biochemistry, Faculty of Pharmacy, Cairo University. Egyptian, date of birth 6/3/1955. Ph.D. in Pharmaceutical Sciences, 1984; M.Sc. in Pharmaceutical Sciences, 1979; B.Sc. in Pharmaceutical Sciences, Faculty of Pharmacy, Cairo University, 1976. Professional experience: Instructor; 1976, Lecturer Assistant; 1980, Lecturer, 1984; Assistant Professor, 1989; Professor,1994; Head of the Department of Biochemistry, Faculty of Pharmacy, Cairo:- 2008-2014.